• Ribometrix Inc, a Greenville, N.C. - based biotech company focused on developing
small molecule modulators of RNA to treat disease, raised $ 7.5 million in seed funding.
Thus, the kinesin - microtubule interaction site could be a useful target
for small molecule modulators, and adociasulfate - 2 should serve as an archetype for specific inhibitors of kinesin functions.
«While genetic and proteomic tools can address the mechanisms of splicing at a global level,
small molecule modulators allow the selective examination of splicing mechanism,» said Burkart.